Proton therapy and the European Particle Therapy Network: The past, present and future.

Weber, D.C.; Langendijk, J A; Grau, C; Thariat, J (2020). Proton therapy and the European Particle Therapy Network: The past, present and future. Cancer radiothérapie, 24(6-7), pp. 687-690. Elsevier Science 10.1016/j.canrad.2020.05.002

Text 1-s2.0-S1278321820301608-main_2_.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (459kB)

Proton therapy is delivered to selected cancer patients presenting with rare tumours, for which a dose escalation paradigm and/or a reduced dose-bath to the organs at risk is pursued. It is a costly treatment with an additional cost factor of 2-3 when compared to photon radiotherapy. Notwithstanding the 180'000 patients treated with protons, scars robust clinical evidence is available to justify the administration of this treatment modality. The European Particle Therapy Network (EPTN) was created in 2015 to answer the critical European needs for cooperation among protons and carbon ions centres in the framework of clinical research networks. EPTN with other European groups will launch a number of prospective clinical trials that could be practice changing if positive. Alternative way to generate clinical data could be provided by alternative methodologies, such as the Dutch model-based approach, or could be provided by European infrastructure projects.

Interest & Impact

Downloads

3 since deposited on 25 Aug 2020
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item